AI CAPITAL INTELLIGENCE
智宠制药 funding history
1 recorded financing disclosures for 智宠制药. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.
Latest recorded funding, at a glance
The latest disclosure recorded for 智宠制药 is dated 2026-10-23: Series A1, CNY 20,000,000–90,000,000 (reported range). Named investors: 天汇资本. This is the latest record in our coverage, not a claim about all company financing.
View funding details · Original source 1 · Original source 2
Funding disclosures
| Disclosure date | Round | Disclosed amount | Named investors | Evidence |
|---|---|---|---|---|
| Series A1 | CNY 20,000,000–90,000,000 (reported range) | 天汇资本 | Record · Source 1 · Source 2 |
Products and focus
Industry AI / Drug discovery & life sciences
- ChemoFetch小分子引擎
- OmniFetch大分子引擎
Recorded financing disclosures
- 智宠制药2026-10-23 · Series A1 · CNY 20,000,000–90,000,000 (reported range)
Disclosed investors across recorded rounds
Publicly disclosed founding team
- 魏文娟 · 创始人、CEO
Source bibliography
- 智宠制药完成数千万元A1轮融资，重塑宠物药研发
news.pedaily.cn · Original publication date not recorded
- 智宠制药完成数千万元A1轮融资，重塑宠物药研发
sohu.com · Original publication date not recorded
Citation and coverage
Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market.
Wavesight AI｜智宠制药 funding history。The latest disclosure recorded for 智宠制药 is dated 2026-10-23: Series A1, CNY 20,000,000–90,000,000 (reported range). Named investors: 天汇资本. This is the latest record in our coverage, not a claim about all company financing. Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market. https://www.zkdlj.vip/en/companies/profile/EN-0d4cd9aa3a416d5a/#conclusion-overview
Link to conclusion